Leucine aminopeptidase assay kit (L-leucyl-p-nitroaniline substrate method) - NMPA Registration 京械注准20232400607
Access comprehensive regulatory information for Leucine aminopeptidase assay kit (L-leucyl-p-nitroaniline substrate method) in the China medical device market through Pure Global AI's free database. This Class II medical device is registered under NMPA registration number 京械注准20232400607 and owned by Beijing Homa Biological Engineering Co., Ltd.. The device was approved on September 27, 2023.
This page provides complete registration details including registrant information, province location (Beijing), intended use, and regulatory compliance data from the official China NMPA medical device database. Pure Global AI offers free access to China's complete medical device registry, helping global MedTech companies navigate NMPA regulations efficiently.
This kit is used for the in vitro quantitative determination of the concentration of leucine aminopeptidase (LAP) in human serum.
本试剂盒用于体外定量测定人血清中亮氨酸氨基肽酶（LAP）的浓度。
This reagent consists of reagent 1 (R1) and reagent 2 (R2). Reagent 1 (R1): HEPES buffer 50 mmol/L NaCL 100mmol/L TritonX-100 0.05% Sodium azide 1g/L Reagent 2 (R2): HEPES buffer 50 mmol/L L-Leucine-4-nitroaniline 15mmol/L Sodium azide 1g/L
本试剂由试剂1（R1）和试剂2（R2）组成 试剂1（R1）： HEPES缓冲液 50mmol/L NaCL 100mmol/L TritonX-100 0.05% 叠氮钠 1g/L 试剂2（R2）： HEPES缓冲液 50mmol/L L-亮氨酸-4-硝基苯胺 15mmol/L 叠氮钠 1g/L
<span style="f